140 related articles for article (PubMed ID: 23561587)
1. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Spadaccio C; Patti G; De Marco F; Coccia R; Di Domenico F; Pollari F; Zanzonico R; Pettinari M; Lusini M; Di Sciascio G; Covino E; Chello M
Am J Cardiol; 2013 Jul; 112(1):21-6. PubMed ID: 23561587
[TBL] [Abstract][Full Text] [Related]
2. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
3. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).
Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK
J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341
[TBL] [Abstract][Full Text] [Related]
4. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
5. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
[TBL] [Abstract][Full Text] [Related]
6. The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting.
Hajizadeh R; Ghaffari S; Separham A; Shokouhi B; Kavandi H; Pourafkari L; Nader ND
Rom J Intern Med; 2017 Dec; 55(4):229-236. PubMed ID: 28672766
[TBL] [Abstract][Full Text] [Related]
7. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
[TBL] [Abstract][Full Text] [Related]
11. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris.
Okada T; Yoshikawa D; Ishii H; Matsumoto M; Hayakawa S; Matsudaira K; Tanaka M; Kumagai S; Hayashi M; Ando H; Amano T; Murohara T
J Cardiol; 2012 Oct; 60(4):264-9. PubMed ID: 22738692
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
13. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.
Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P
Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512
[TBL] [Abstract][Full Text] [Related]
14. Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses.
Markovic S; Paliskyte R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2012; 13(6):307-10. PubMed ID: 23164475
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
[TBL] [Abstract][Full Text] [Related]
16. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
[TBL] [Abstract][Full Text] [Related]
17. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry.
Sugihara M; Miura S; Nishikawa H; Ike A; Mori K; Iwata A; Kawamura A; Saku K
J Cardiol; 2013 Feb; 61(2):117-21. PubMed ID: 23159206
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
